| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/22/2010 | US20100184668 method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 07/22/2010 | US20100184660 Single exon genes encoding for novel bio-active peptides |
| 07/22/2010 | US20100184657 Methods of treating epithelial lesions outside the stomach and intestines |
| 07/22/2010 | US20100184656 Pantropic neurotrophic factors |
| 07/22/2010 | US20100184628 Bis-sulfhydryl macrocyclization systems |
| 07/22/2010 | US20100184193 OVEREXPRESSION OF AMINOACYL-tRNA SYNTHETASES FOR EFFICIENT PRODUCTION OF ENGINEERED PROTEINS CONTAINING AMINO ACID ANALOGUES |
| 07/22/2010 | US20100184149 Method For Producing a Biopolymer (e.g. polypeptide) In A Continuous Fermentation Process |
| 07/22/2010 | US20100184148 In vitro germinal centers |
| 07/22/2010 | US20100184147 METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD |
| 07/22/2010 | US20100184146 Plasmid for expressing thioredoxin fusion protein and method for producing target protein using same |
| 07/22/2010 | US20100184145 Antibody-based therapeutics with enhanced adcc activity |
| 07/22/2010 | US20100184144 Immunoglobulin production |
| 07/22/2010 | US20100184143 Immunoglobulins comprising predominantly a Man3GlcNAc2 glycoform |
| 07/22/2010 | US20100184142 DNA sequences coding a translocon ATPase and a intramolecular regulator of ATP hydrolysis regulatory sequence for use in vector in order to enhance expression and transport of heterologous gene and polypeptides |
| 07/22/2010 | US20100184141 Serum-free Stable Transfection and Production of Recombinant Human Proteins in Human Cell Lines |
| 07/22/2010 | US20100184140 cells comprising a translation system comprising an synthetase enzymes encoded by a nucleotide sequence and the complementary polynucleotide sequence; protein biosynthesis |
| 07/22/2010 | US20100184139 BASB082 polynucleotides |
| 07/22/2010 | US20100184138 Heterologous and Homologous Cellulase Expression System |
| 07/22/2010 | US20100184137 Modified secretion system to increase expression of polypeptides in bacteria |
| 07/22/2010 | US20100184136 Methods For Enhancing A Secretion Efficiency Of Recombinant Foreign Protein In Yeast Expression System |
| 07/22/2010 | US20100184135 Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system |
| 07/22/2010 | US20100184134 Dual charging system for selectively introducing non-native amino acids into proteins using an in vitro synthesis method |
| 07/22/2010 | US20100184133 Method for making maturated insulin polypeptides |
| 07/22/2010 | US20100184132 Enzymatic Process for Debittering of Protein Hydrolysate Using Immobilized Peptidases |
| 07/22/2010 | US20100184111 comprising N-{3-(hydroxyaminocarbonyl)-1-oxo-(2R)-benzylpropyl}-Ile-Leu-OH as in catalytic domain of modified tumor necrosis factor-alpha converting enzyme; less susceptible to autoproteolysis; drug design; host cells; computers |
| 07/22/2010 | US20100184090 Method for Generating Stable Cell Lines Expressing High Levels of a Protein of Interest |
| 07/22/2010 | US20100184085 Prokaryotic collage-like proteins and uses thereof |
| 07/22/2010 | US20100184038 System and Method For the Heterologous Expression of Polyketide Synthase Gene Clusters |
| 07/22/2010 | US20100184021 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis |
| 07/22/2010 | US20100184014 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/22/2010 | US20100183765 Asparaginase enzyme variants and uses thereof |
| 07/22/2010 | US20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof |
| 07/22/2010 | US20100183649 Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system |
| 07/22/2010 | US20100183643 Cancer vaccines containing epitopes of oncofetal antigen |
| 07/22/2010 | US20100183618 Anti-epha2 antibody |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183595 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 07/22/2010 | US20100183572 Cell capable of expressing lacritin at high level |
| 07/22/2010 | US20100183566 METHOD FOR EFFICIENT TRANSFER OF HUMAN BLASTOCYST-DERIVED STEM CELLS (hBS CELLS) FROM A FEEDER-SUPPORTED TO A FEEDER-FREE CULTURE SYSTEM |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183546 Method for Increasing CD8+ Cytotoxic T Cell Responses and for Treating Multiple Sclerosis |
| 07/22/2010 | US20100183516 Self coupling recombinant antibody fusion proteins |
| 07/22/2010 | DE102004016985B4 Aerosolerzeugungsvorrichtung und Inhalationsvorrichtung Aerosol generating device and inhalation device |
| 07/22/2010 | CA2749396A1 A method for increasing protein expression in cells |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |
| 07/21/2010 | EP2208783A1 Method of producing an antibody using a cell in which the function of fucose transporter is inhibited |
| 07/21/2010 | EP2208732A1 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use |
| 07/21/2010 | EP2207890A1 High pressure treatment of aggregated interferons |
| 07/21/2010 | EP2207804A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 07/21/2010 | EP2207563A1 Preventive and therapeutic vaccine for stroke and neurological disorders |
| 07/21/2010 | EP1412502B1 Use of clya hemolysin for excretion of fusion proteins |
| 07/21/2010 | EP1369476B1 A novel protein, a gene encoding therefor and a method of using the same |
| 07/21/2010 | EP1265928B1 Ultra high affinity rsv neutralizing antibodies |
| 07/21/2010 | EP1124961B9 Thrombopoietic compounds |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN101784670A Glycosylation profile analysis |
| 07/21/2010 | CN101784666A A recombinant host cell for the production of a compound of interest |
| 07/21/2010 | CN101784655A Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 07/21/2010 | CN101784566A Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 07/21/2010 | CN101784565A conjugates containing hydrophilic spacer linkers |
| 07/21/2010 | CN101781672A Process for preparing hydrolyzed II-type collagen |
| 07/21/2010 | CN101781671A Method for separating and purifying corn antioxidant peptide |
| 07/21/2010 | CN101781670A Fermentation technology of exogenous protein large-scale preparation by using Kluyveromyces cicerisporus expression system |
| 07/21/2010 | CN101781656A Expression of odontoglossum ringspot virus (ORSV) coat protein gene and preparation method of antibody |
| 07/21/2010 | CN101781642A Culture medium for identifying differential protein components in Trichoderma koningii cellulose system and application thereof |
| 07/21/2010 | CN101781635A Plant cell having animal-type sugar chain adding function |
| 07/21/2010 | CN101781625A Ethionine resistance Candida utilis and application thereof |
| 07/21/2010 | CN101781368A Anti-amyloid beta antibodies and their use |
| 07/21/2010 | CN101240254B Organic solvent resisting proteinase high-yield bacterium, gene and application of the organic solvent resisting proteinase |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759475 Enzyme expression methods and compositions |
| 07/20/2010 | US7759466 Monoclonal antibodies to alpha-amylase |
| 07/20/2010 | US7759465 selectively inhibit induction of cytokines by human peripheral blood mononuclear cells (PBMCs) stimulated with ara-lipoarabinomannan (araLAM); for inflammation |
| 07/20/2010 | US7759463 RNA interference pathway genes as tools for targeted genetic interference |
| 07/20/2010 | US7759462 detecting Tir polypeptide of escherichia by contacting a sample with an anti-Tir (translocated intimin receptor) antibody immunospecific to the Tir polypeptide and detecting immunospecific binding of the anti-Tir antibody to the Tir polypeptide;kits |
| 07/20/2010 | US7759303 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone |
| 07/20/2010 | US7759107 Thermostable nucleic acid polymerase from Thermococcus gorgonarius |
| 07/20/2010 | US7759106 Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli |
| 07/20/2010 | US7759102 Talaromyces xylanases |
| 07/20/2010 | US7759100 polynucleotide expressed in Flammulina velutipes against 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide |
| 07/20/2010 | US7759094 Method for the production of L-amino acids using strains from the Enterobacteriaceae family which contain an enhanced lamb gene |
| 07/20/2010 | US7759092 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759090 Expression system for producing collagen |
| 07/20/2010 | US7759089 Starch binding domain as a tag for easier and less expensive purification of recombinant proteins using affinity matrix |
| 07/20/2010 | US7759088 Having up to 5,000 times water absorption capacity, improved firmness, and long-term stability after full swelling in water or an aqueous medium; for use in cosmetics, agricultural and horticultural, civil construction, medical and hygiene, or bioengineering applications |
| 07/20/2010 | US7759087 introducing to a cell culture an inoculum containing an infective dose of HCV, contacting the culture with a growth medium containing an excess of uridine and cytidine, changing spent growth medium with fresh growth medium containing the excess of uridine and cytidine on a predetermined schedule |
| 07/20/2010 | US7759059 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition |
| 07/20/2010 | US7758859 monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 07/20/2010 | US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 07/20/2010 | CA2421339C Novel polypeptides and nucleic acids encoding the same |
| 07/20/2010 | CA2389250C Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 07/20/2010 | CA2309679C Method of identifying binding site domains that retain the capacity of binding to an epitope |
| 07/20/2010 | CA2191063C Dna encoding glutamate gated chloride channels |
| 07/20/2010 | CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it |
| 07/15/2010 | WO2010081111A1 Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system |
| 07/15/2010 | WO2010080506A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/15/2010 | WO2010079594A1 Sterol side chain-cleaving enzyme protein and use thereof |
| 07/15/2010 | WO2010060056A3 Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose |
| 07/15/2010 | US20100179092 Human complement c3 derivatives with cobra venom factor-like function |